• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性休克住院治疗后同一病原体败血症再入院的危险因素。

Risk Factors for Same Pathogen Sepsis Readmission Following Hospitalization for Septic Shock.

作者信息

Kim June-Sung, Kim Youn-Jung, Ryoo Seung Mok, Sohn Chang Hwan, Ahn Shin, Seo Dong Woo, Lim Kyoung Soo, Kim Won Young

机构信息

Department of Emergency Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea.

出版信息

J Clin Med. 2019 Feb 3;8(2):181. doi: 10.3390/jcm8020181.

DOI:10.3390/jcm8020181
PMID:30717469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6406311/
Abstract

(1) Background: Septic shock survivors frequently readmit because of subsequent infection. This study aimed to determine the rate and risk factors for same pathogen sepsis readmissions following hospitalization for septic shock. (2) Methods: We performed this retrospective study using data from a prospective septic shock registry at a single urban tertiary center. All the patients were treated with a protocol-driven resuscitation bundle therapy between 2011 and 2016. We collected data from adult (older than 18 years) patients readmitted with sepsis within 90 days of discharge following hospitalization for septic shock. (3) Results: Among 2062 septic shock patients, 690 were readmitted within 90 days of discharge. After excluding scheduled and non-sepsis admissions, we analyzed the data from 274 (13.3%) patients readmitted for sepsis. Most of the readmissions following septic shock were new infections rather than relapses of the initial infection. The culture-negative rate was 51.4% (141/274), while the same pathogen was isolated in 25% of cases (69/274). Multivariate analysis revealed that previous gram-negative bacteremia (OR, 9.902; 95% CI, 2.843⁻34.489), urinary tract infection (OR, 4.331; 95% CI, 1.723⁻10.882) and same site infection (OR, 6.894; 95% CI, 2.390⁻19.886) were significantly associated with readmission for sepsis caused by the same pathogen. (4) Conclusions: The sepsis readmission rate following the previous hospitalization for septic shock was 13.3% and one-quarter of those patients had the same pathogen isolated. Previous gram-negative bacteremia, and/or same site infection are predisposing factors for recurrent same-pathogen sepsis.

摘要

(1) 背景:感染性休克幸存者常因后续感染再次入院。本研究旨在确定感染性休克住院后同一病原体败血症再入院的发生率及危险因素。(2) 方法:我们利用一家城市三级中心前瞻性感染性休克登记处的数据进行了这项回顾性研究。2011年至2016年期间,所有患者均接受了方案驱动的复苏集束治疗。我们收集了因感染性休克住院出院后90天内再次入院的成年(年龄大于18岁)败血症患者的数据。(3) 结果:在2062例感染性休克患者中,690例在出院后90天内再次入院。排除计划性和非败血症性入院后,我们分析了274例(13.3%)因败血症再次入院患者的数据。感染性休克后的大多数再入院是新感染而非初始感染的复发。血培养阴性率为51.4%(141/274),25%的病例(69/274)分离出同一病原体。多因素分析显示,既往革兰阴性菌血症(OR,9.902;95%CI,2.843⁻34.489)、尿路感染(OR,4.331;95%CI,1.723⁻10.882)和同一部位感染(OR,6.894;95%CI,2.390⁻19.886)与同一病原体引起的败血症再入院显著相关。(4) 结论:既往感染性休克住院后的败血症再入院率为13.3%,其中四分之一的患者分离出同一病原体。既往革兰阴性菌血症和/或同一部位感染是复发性同一病原体败血症的易感因素。

相似文献

1
Risk Factors for Same Pathogen Sepsis Readmission Following Hospitalization for Septic Shock.感染性休克住院治疗后同一病原体败血症再入院的危险因素。
J Clin Med. 2019 Feb 3;8(2):181. doi: 10.3390/jcm8020181.
2
Readmissions for Recurrent Sepsis: New or Relapsed Infection?复发性脓毒症再入院:新发感染还是复发感染?
Crit Care Med. 2017 Oct;45(10):1702-1708. doi: 10.1097/CCM.0000000000002626.
3
Risk factors for 30-day readmission among patients with culture-positive severe sepsis and septic shock: A retrospective cohort study.培养结果阳性的严重脓毒症和脓毒性休克患者30天再入院的危险因素:一项回顾性队列研究。
J Hosp Med. 2015 Oct;10(10):678-85. doi: 10.1002/jhm.2420. Epub 2015 Jul 20.
4
Lactate Level Versus Lactate Clearance for Predicting Mortality in Patients With Septic Shock Defined by Sepsis-3.乳酸水平与乳酸清除率对 Sepsis-3 定义的脓毒性休克患者病死率的预测价值
Crit Care Med. 2018 Jun;46(6):e489-e495. doi: 10.1097/CCM.0000000000003030.
5
Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection.革兰氏阴性菌引起的脓毒症经验性治疗无效的危险因素和结局:按感染发生时间分层。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01577-17. Print 2018 Jan.
6
Variation in Postsepsis Readmission Patterns: A Cohort Study of Veterans Affairs Beneficiaries.脓毒症后再入院模式的差异:一项针对退伍军人事务部受益人的队列研究。
Ann Am Thorac Soc. 2017 Feb;14(2):230-237. doi: 10.1513/AnnalsATS.201605-398OC.
7
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
8
Prognostic Value of the Time-to-Positivity in Blood Cultures from Septic Shock Patients with Bacteremia Receiving Protocol-Driven Resuscitation Bundle Therapy: A Retrospective Cohort Study.接受方案驱动复苏集束治疗的菌血症性脓毒症休克患者血培养阳性时间的预后价值:一项回顾性队列研究
Antibiotics (Basel). 2021 Jun 8;10(6):683. doi: 10.3390/antibiotics10060683.
9
Association of Fluid Resuscitation Initiation Within 30 Minutes of Severe Sepsis and Septic Shock Recognition With Reduced Mortality and Length of Stay.严重脓毒症和脓毒性休克识别后30分钟内开始液体复苏与降低死亡率及缩短住院时间的关联。
Ann Emerg Med. 2016 Sep;68(3):298-311. doi: 10.1016/j.annemergmed.2016.02.044. Epub 2016 Apr 14.
10
Appropriateness of Broad Spectrum Antibiotics for Severe Sepsis and Septic Shock in the Emergency Department.急诊科广谱抗生素用于严重脓毒症和脓毒性休克的合理性
J Med Assoc Thai. 2016 May;99(5):477-83.

引用本文的文献

1
High-cost users after sepsis: a population-based observational cohort study.脓毒症高花费患者:一项基于人群的观察性队列研究。
Crit Care. 2024 Oct 21;28(1):338. doi: 10.1186/s13054-024-05108-6.
2
One-year hospital readmission for recurrent sepsis: associated risk factors and impact on 1-year mortality-a French nationwide study.一年内因复发性败血症再次入院:相关风险因素及对 1 年死亡率的影响——一项法国全国性研究。
Crit Care. 2022 Nov 29;26(1):371. doi: 10.1186/s13054-022-04212-9.
3
Prevalence and Long-Term Prognosis of Post-Intensive Care Syndrome after Sepsis: A Single-Center Prospective Observational Study.

本文引用的文献

1
Temporal Trends in Incidence, Sepsis-Related Mortality, and Hospital-Based Acute Care After Sepsis.脓毒症发病、与脓毒症相关的死亡率和脓毒症后医院急性治疗的时间趋势。
Crit Care Med. 2018 Mar;46(3):354-360. doi: 10.1097/CCM.0000000000002872.
2
Culture-Negative Septic Shock Compared With Culture-Positive Septic Shock: A Retrospective Cohort Study.文化阴性感染性休克与文化阳性感染性休克的比较:一项回顾性队列研究。
Crit Care Med. 2018 Apr;46(4):506-512. doi: 10.1097/CCM.0000000000002924.
3
Organ dysfunction as a new standard for defining sepsis.器官功能障碍作为定义脓毒症的新标准。
脓毒症后重症监护综合征的患病率及长期预后:一项单中心前瞻性观察研究
J Clin Med. 2022 Sep 6;11(18):5257. doi: 10.3390/jcm11185257.
4
Prognostic Value of the Time-to-Positivity in Blood Cultures from Septic Shock Patients with Bacteremia Receiving Protocol-Driven Resuscitation Bundle Therapy: A Retrospective Cohort Study.接受方案驱动复苏集束治疗的菌血症性脓毒症休克患者血培养阳性时间的预后价值:一项回顾性队列研究
Antibiotics (Basel). 2021 Jun 8;10(6):683. doi: 10.3390/antibiotics10060683.
5
Characteristics and clinical outcomes of culture-negative and culture-positive septic shock: a single-center retrospective cohort study.培养阴性和培养阳性脓毒性休克的特征和临床结局:一项单中心回顾性队列研究。
Crit Care. 2021 Jan 6;25(1):11. doi: 10.1186/s13054-020-03421-4.
6
Rate and risk factors for rehospitalisation in sepsis survivors: systematic review and meta-analysis.脓毒症幸存者再入院的比率和风险因素:系统评价和荟萃分析。
Intensive Care Med. 2020 Apr;46(4):619-636. doi: 10.1007/s00134-019-05908-3. Epub 2020 Jan 23.
7
Usefulness of the Thrombotic Microangiopathy Score as a Promising Prognostic Marker of Septic Shock for Patients in the Emergency Department.血栓性微血管病评分作为急诊科感染性休克患者有前景的预后标志物的实用性。
J Clin Med. 2019 Jun 6;8(6):808. doi: 10.3390/jcm8060808.
Inflamm Regen. 2016 Nov 15;36:24. doi: 10.1186/s41232-016-0029-y. eCollection 2016.
4
Repeat gram-negative hospital-acquired infections and antibiotic susceptibility: A systematic review.重复革兰氏阴性医院获得性感染和抗生素敏感性:系统评价。
J Infect Public Health. 2018 Jul-Aug;11(4):455-462. doi: 10.1016/j.jiph.2017.09.024. Epub 2017 Oct 20.
5
Readmissions for Recurrent Sepsis: New or Relapsed Infection?复发性脓毒症再入院:新发感染还是复发感染?
Crit Care Med. 2017 Oct;45(10):1702-1708. doi: 10.1097/CCM.0000000000002626.
6
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动:脓毒症和脓毒性休克管理国际指南:2016 年版。
Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18.
7
Sepsis-induced immune dysfunction: can immune therapies reduce mortality?脓毒症诱导的免疫功能障碍:免疫疗法能否降低死亡率?
J Clin Invest. 2016 Jan;126(1):23-31. doi: 10.1172/JCI82224. Epub 2016 Jan 4.
8
The microbiome and critical illness.微生物组与危重病。
Lancet Respir Med. 2016 Jan;4(1):59-72. doi: 10.1016/S2213-2600(15)00427-0. Epub 2015 Dec 12.
9
Association Between Index Hospitalization and Hospital Readmission in Sepsis Survivors.脓毒症幸存者首次住院与再次入院之间的关联
Crit Care Med. 2016 Mar;44(3):478-87. doi: 10.1097/CCM.0000000000001464.
10
Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance.严重脓毒症和脓毒性休克的经验性抗菌治疗:优化病原体清除
Curr Infect Dis Rep. 2015 Jul;17(7):493. doi: 10.1007/s11908-015-0493-6.